Advertisement

Topics

Gambro Inc. Company Profile

22:51 EDT 18th June 2018 | BioPortfolio

Gambro’s business concept is to develop, manufacture, market and provide products and services within the areas of dialysis, intensive care, blood bank technology and therapeutics. Gambro is dedicated to advancing healthcare and improving patient outcomes by providing those we serve with the tools they need. These people are our inspiration, which is why we work closely with them on a day-to-day basis to understand and deliver new solutions that make a difference. In 2005 Gambro entered into a new phase in its long term development. The divestment of the U.S. clinics was finalized and Gambro is now a smaller but more focused company in the field of medical technology and related services.People’s lives depend on the products, our services and the care we provide. This powerful driving force, combined with an ability to constantly innovate and solve problems by thinking creatively, keeps Gambro at the forefront of our industry’s development. To Gambro, Progress means that we view every challenge through the lens of innovation. The spirit of progress is evident in every one of our cornerstones, as well as in our vision and core purpose. But more importantly, the spirit of progress is evident in every Gambro employee. “Progress” implies that we continuously strive to improve our products and services, and thereby continuously strive to improve the lives of the people who depend on them. “It’s in our blood” not only reflects the heart of the business in which we work, but also expresses the depth of our commitment to patients, doctors and everyone else who is touched by the spirit of Gambro.

Location

10810 W. Collins Avenue
Lakewood
Colorado
80215-4498
United States of America

Contact

Phone: 1 - 303 232 6800
Fax: 1 - 303 231 4915


News Articles [4 Associated News Articles listed on BioPortfolio]

Global and North America Disposable Hemoperfusion Market Status and Future Forecast 20132023 [Report Updated: 24012018] Prices from USD $2500

SummaryKey Content of Chapters Including and can be customizedPart 1:Market Overview, Development, and Segment by Type, Application RegionPart 2:Global Market by company, Type, Application RegionPar...

Global and Europe Dialysis Water Treatment Market Status and Future Forecast 20132023 [Report Updated: 11012018] Prices from USD $3500

SummaryKey Content of Chapters Including and can be customizedPart 1:Market Overview, Development, and Segment by Type, Application RegionPart 2:Global Market by company, Type, Application RegionPar...

OrthoNOW® Names Healthcare Industry Veteran Nick Mendez CEO

Dr. Alejandro Badia Will Focus On Role as Chief Medical Officer Organizational Changes Made to Align with OrthoNOW’s Growth Strategy OrthoNOW has announced t...

20152023 World Disposable Hemoperfusion Market Research Report by Product Type, EndUser / Application and Regions / Countries [Report Updated: 20122017] Prices from USD $2800

SummaryHemoperfusion is a treatment technique in which large volumes of the patient's blood are passed over an adsorbent substance in order to remove toxic substances from the blood. Adsorption is a p...

PubMed Articles [0 Results]

None

Clinical Trials [4 Associated Clinical Trials listed on BioPortfolio]

Ease of Use Study for the Gambro Polyflux HD-C4 Small Dialyzer

The purpose of the study is to study the ease of use of the Polyflux HD-C4 Small dialyzer under conditions of routine clinical use for hemodialysis

Ease of Use and Blood Clotting for the Gambro Polyflux HD-C4 Big Dialyzer

The purpose of this study is to collect information on the ease of use and thrombogenicity of the Polyflux HD-C4 Big and Fresenius Optiflux 180NR or 200NR dialyzers under conditions of rou...

Prismaflex HF20 Set and Prismaflex® System 7.10 for Acute CRRT in Children

The primary objective of this study is to evaluate the efficacy of the Gambro Prismaflex® HF20 Set based on testing the hypothesis that it delivers sufficient renal replacement therapy to...

European Trial of Free Light Chain Removal by Extended Haemodialysis in Cast Nephropathy

Hypothesis: Free light chain removal haemodialysis will increase the rate of renal recovery in patients with cast nephropathy, severe renal failure and de novo multiple myeloma. This stud...

Companies [4 Associated Companies listed on BioPortfolio]

Gambro BCT, Inc

Gambro BCT is an international company with operations in over 50 countries across the globe. Wherever we are, our commitment to building partnerships and better patient outcomes is unwavering

Gambro Inc.

Gambro’s business concept is to develop, manufacture, market and provide products and services within the areas of dialysis, intensive care, blood bank technology and therapeutics. Gambro is dedica...

Gambro

Ultrafiltration is an extracorporeal treatment in which water, salt, and other blood constituents are removed by a filter. Ultrafiltration was first prescribed as a therapy for diuretic resistant pati...

Gambro Renal Care Product Inc

HOSPAL was founded in 1977 by the merger of the artificial kidney operations of two European chemical and pharmaceutical companies, Rhône-Poulenc and Sandoz. Both companies had been active in this ra...

More Information about "Gambro Inc." on BioPortfolio

We have published hundreds of Gambro Inc. news stories on BioPortfolio along with dozens of Gambro Inc. Clinical Trials and PubMed Articles about Gambro Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Gambro Inc. Companies in our database. You can also find out about relevant Gambro Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...


Corporate Database Quicklinks



Searches Linking to this Company Record